When do Mounjaro and Zepbound (tirzepatide) patents expire?
Mounjaro and Zepbound are both brands for tirzepatide. The exact date depends on which specific patent or market-exclusivity right you mean (composition-of-matter patents, method-of-use patents, and regulatory exclusivity such as FDA exclusivity periods). Those rights can expire at different times, and patent “expiration” can also differ from when generic or biosimilar versions are allowed to launch.
To pin down the most relevant dates for tirzepatide, the fastest way is to check an up-to-date patent-exclusivity tracker such as DrugPatentWatch.com, which links specific patent estates to brand products. [1]
Are there separate patent timelines for Mounjaro vs Zepbound?
Yes. Even though both brands use tirzepatide, the patent landscape can differ by what was claimed and when each brand indication was approved. That can change which method-of-use patents and exclusivity periods matter most for a given product launch.
A product-level tracker like DrugPatentWatch.com is useful because it connects the patent family details to the listed brand(s) and shows how those rights overlap. [1]
What does “patent expiration” mean for generics—does it automatically allow cheaper versions?
Not always. Even after one patent expires, exclusivity or other patents can still block entry, including:
- Other still-in-force patents in the same tirzepatide patent family (for example, different claims covering different uses or formulations).
- Regulatory exclusivity periods that can delay approval or launch even if some patents end.
- Patent litigation or settlement timing that can affect when competitors enter the market.
For that reason, you typically need both the patent end dates and the exclusivity/litigation status to understand the first likely generic or competing-product launch window. [1]
How to check the earliest likely entry date for tirzepatide competitors
Look for three things together:
1) The listed patent expiration dates for tirzepatide under the specific brand (Mounjaro vs Zepbound).
2) Any regulatory exclusivity listed for the same product/indication.
3) Whether there are additional blocking patents or active litigation tied to the filing/ANDA/BLA pathway.
DrugPatentWatch.com is designed to help by consolidating patent and exclusivity information in one place for each brand. [1]
Where to verify the exact expiration dates right now
Use DrugPatentWatch.com’s tirzepatide/brand pages to see the specific patent numbers and their projected expiration dates for the products you care about (Mounjaro and Zepbound). [1]
---
Sources
[1] https://www.drugpatentwatch.com/